Swiss National Bank Allogene Therapeutics, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 264,900 shares of ALLO stock, worth $556,290. This represents 0.0% of its overall portfolio holdings.

Number of Shares

264,900

Previous 287,000 7.7%

Holding current value

$556,290

Previous $668,000 10.93%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$2.08 - $3.5 $45,968 - $77,350	-22,100 Reduced 7.7%	264,900 $741,000
Q2 2024 Aug 08, 2024	BUY	$2.23 - $4.38 $161,006 - $316,236	72,200 Added 33.61%	287,000 $668,000
Q4 2023 Feb 06, 2024	BUY	$2.28 - $3.5 $51,071 - $78,400	22,400 Added 11.64%	214,800 $689,000
Q3 2023 Nov 08, 2023	BUY	$3.17 - $5.96 $17,752 - $33,376	5,600 Added 3.0%	192,400 $609,000
Q1 2023 May 10, 2023	SELL	$4.92 - $8.21 $106,272 - $177,336	-21,600 Reduced 10.36%	186,800 $922,000
Q4 2022 Feb 08, 2023	BUY	$5.62 - $11.11 $23,042 - $45,551	4,100 Added 2.01%	208,400 $1.31 Million
Q3 2022 Nov 09, 2022	BUY	$10.32 - $17.28 $25,800 - $43,200	2,500 Added 1.24%	204,300 $2.21 Million
Q2 2022 Aug 09, 2022	BUY	$6.78 - $12.28 $111,192 - $201,392	16,400 Added 8.85%	201,800 $2.3 Million
Q1 2022 May 09, 2022	BUY	$7.65 - $15.29 $102,510 - $204,886	13,400 Added 7.79%	185,400 $1.69 Million
Q3 2021 Nov 08, 2021	BUY	$21.01 - $27.64 $31,515 - $41,460	1,500 Added 0.88%	172,000 $4.42 Million
Q2 2021 Aug 06, 2021	BUY	$23.49 - $35.8 $617,787 - $941,539	26,300 Added 18.24%	170,500 $4.45 Million
Q1 2021 May 07, 2021	BUY	$25.79 - $39.02 $64,475 - $97,550	2,500 Added 1.76%	144,200 $5.09 Million
Q4 2020 Feb 05, 2021	BUY	$25.24 - $43.45 $350,836 - $603,955	13,900 Added 10.88%	141,700 $3.58 Million
Q3 2020 Nov 09, 2020	BUY	$32.38 - $44.96 $77,712 - $107,904	2,400 Added 1.91%	127,800 $4.82 Million
Q2 2020 Aug 05, 2020	BUY	$18.39 - $54.04 $1.44 Million - $4.22 Million	78,100 Added 165.12%	125,400 $5.37 Million
Q1 2020 May 08, 2020	BUY	$18.22 - $28.25 $12,754 - $19,775	700 Added 1.5%	47,300 $920,000
Q4 2019 Feb 06, 2020	BUY	$24.82 - $31.4 $34,748 - $43,960	1,400 Added 3.1%	46,600 $1.21 Million
Q2 2019 Aug 02, 2019	BUY	$25.56 - $31.09 $1.16 Million - $1.41 Million	45,200 New	45,200 $1.21 Million

Others Institutions Holding ALLO

# of Institutions

163

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $302M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Allogene Therapeutics, Inc. Transaction History